Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China
Authors:
Open Access
- 27 March 2017
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 45 (6) , 1779-1786
Abstract
To investigate the prevalence and risk factors associated with multi-drug resistant tuberculosis (MDR–TB) in Dalian, China. This was a retrospective review of data from patients attending a TB clinic in Dalian, China between 2012 and 2015. Demographic and drug susceptibility data were retrieved from TB treatment cards. Univariate logistic analysis was used to assess the association between risk factors and MDR–TB. Among the 3552 patients who were smear positive for Mycobacterium tuberculosis (MTB), 2918 (82.2%) had positive MTB cultures and 1106 (31.1%) had isolates that showed resistance to at least one drug. The overall prevalence of MDR–TB was 10.1% (359/3552; 131/2261 [5.8%] newly diagnosed and 228/1291 [17.7%] previously treated patients). Importantly, 75 extensively drug-resistant TB isolates were detected from 25 newly treated and 50 previously treated patients. In total, 215 (6.1%) patients were infected with a poly-resistant strain of MTB. Previously treated patients and older patients were more likely to develop MDR–TB. The study showed a high prevalence of MDR–TB among the study population. History of previous TB treatment and older age were associated with MDR–TB.Keywords
This publication has 14 references indexed in Scilit:
- Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challengesClinical Medicine, 2014
- Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007Emerging Infectious Diseases, 2014
- Epidemic Spread of Multidrug-Resistant Tuberculosis in Johannesburg, South AfricaJournal of Clinical Microbiology, 2013
- Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause MortalityPLOS ONE, 2013
- Delamanid for Multidrug-Resistant Pulmonary TuberculosisNew England Journal of Medicine, 2012
- National Survey of Drug-Resistant Tuberculosis in ChinaNew England Journal of Medicine, 2012
- Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, ChinaEmerging Infectious Diseases, 2011
- Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance SurveillanceThe Lancet, 2009
- Prevalence of tuberculosis drug resistance in 10 provinces of ChinaBMC Infectious Diseases, 2008
- Risk factors for multidrug resistant tuberculosis in Europe: a systematic reviewThorax, 2006